Telemetry Investments’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Telemetry Investments’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,000	Closed	-$376K	–	203
2022 Q2	$376K	Buy	+5,000	New	+$222K	0.45%	73

Telemetry Investments's TPTX Position: Q3 2022 in Review

Telemetry Investments sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 5,000 shares — an estimated $376K sold.

Telemetry Investments first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $376K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Telemetry Investments reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Telemetry Investments sold 5,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $376K.
Telemetry Investments first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Telemetry Investments's Turning Point Therapeutics, Inc. Common Stock position peaked at $376K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Telemetry Investments's 13F filing for Q3 2022, filed 17 Nov 2022.